Centogene N.V. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 189.92 million compared to EUR 128.38 million a year ago. Net loss was EUR 46.85 million compared to EUR 21.38 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4429 USD | +2.04% | -9.41% | -63.09% |
04-02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
03-19 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.09% | 12.34M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- CNTG Stock
- News Centogene N.V.
- Centogene N.V. Reports Earnings Results for the Full Year Ended December 31, 2021